ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,251Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 623

$546K Total Retail Price of All Prescriptions

Rank: 32 out of 623

307 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 307 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 307 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 4,453 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
PRAVASTATIN SODIUM 184 150 1 11
OMEPRAZOLE 182 141 2 7
SIMVASTATIN 168 152 3 2
HYDROCODONE-ACETAMINOPHEN 147 96 S3 4 17
LEVOTHYROXINE SODIUM 139 118 5 4
AMLODIPINE BESYLATE 138 121 6 3
FUROSEMIDE 123 93 7 5
LISINOPRIL 119 107 8 1
OXYCODONE HCL-ACETAMINOPHEN 111 54 S2 9 113
CYMBALTA 110 64 10 52
ZOLPIDEM TARTRATE 99 59 11 22
SERTRALINE HCL 98 87 12 20
CRESTOR 92 78 13 28
ATENOLOL 87 63 14 12
ENDOCET 84 32 S2 15 123
DONEPEZIL HCL 80 80 16 27
AZITHROMYCIN 78 53 17 45
OXYCODONE HCL 78 39 S2 17 30
GLYBURIDE 77 51 R 19 103
OXYCODONE-ACETAMINOPHEN 73 35 S2 20 42
ATORVASTATIN CALCIUM 70 51 21 10
WARFARIN SODIUM 70 57 21 14
METOPROLOL TARTRATE 68 54 23 9
METFORMIN HCL 67 55 24 6
NEXIUM 67 39 24 43
GABAPENTIN 65 41 26 18
METOPROLOL SUCCINATE 61 50 27 13
PREDNISONE 60 31 28 40
PROAIR HFA 53 41 29 57
LOSARTAN POTASSIUM 53 51 29 16
BISOPROLOL-HYDROCHLOROTHIAZIDE 52 44 31 142
POTASSIUM CHLORIDE 51 42 32 24
HYDROCHLOROTHIAZIDE 51 46 32 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.